Medical beauty
Medical beautyinternational patient acquisition
Dermatology, aesthetic clinics, and cosmetic surgery attracting international patients. KHIDI reports 2.01 million international patients in 2025, but provider-level Japanese demand and profitability require separate validation.
Entry requirements
- Named owner for foreign-language consultation, consent, and aftercare
- Established pricing, cancellation, refund, and complaint processes
- Medical advertising compliance and foreign-patient registration confirmed
- Operating capacity to accept additional qualified consultations
Key barriers
- Building a high-trust pre-consultation flow that matches patient LTV
- Medical advertising regulations and permitted claim standards in Japan and Korea
- Designing the discovery-to-booking path across local search, reviews, and community
- Standardizing inquiry response, booking handoff, and no-show prevention
RIVACTA execution approach
- 01SEO and GEO content built around local search demand and comparison intent
- 02Trust page structure covering reviews, pricing, recovery, and FAQ
- 03Inquiry response, booking handoff, and aftercare operations baseline
- 04Search advertising execution within medical advertising regulatory limits
KPI framework
- 01
Qualified native-language consultation inquiries
- 02
Inquiry-to-booking and booking-to-treatment conversion
- 03
Patient acquisition cost against treatment lifetime value
- 04
Repeat visit and referral rate after aftercare
Related insights
Frequently Asked Questions
- Can you guarantee patient volume or medical outcomes?
- No. Medical and regulatory claims are off-limits; we structure compliant acquisition and defer all medical and clinical judgment to your licensed reviewer.
- How do you handle medical advertising regulations?
- We adapt messaging to local medical advertising rules and flag restricted claims, which your designated reviewer or counsel must approve before publishing.
- What does a medical-beauty engagement actually cover?
- Market readiness, compliant positioning, and qualified-inquiry acquisition — not clinical advice or guaranteed treatment results.
- What legal registrations are required to attract international patients to Korea?
- Applicable registration, advertising, consent, privacy, and aftercare requirements depend on the operating structure. Before launch, the clinic owner and a designated legal or medical specialist must confirm those requirements. RIVACTA does not make that determination.
- Which digital channels work best for international patient acquisition in Asia?
- There is no universal channel. After demand and operational readiness are verified, start with the most measurable option among local search, social, messaging, and owned multilingual content. The clinic owner or designated specialist must approve regulated claims before launch.
Regulatory notice
Depending on the target market and category, licensing, labeling, advertising, and privacy rules may apply. RIVACTA identifies the evidence and owner required before execution; legal or regulated decisions remain with the client's designated specialist.
Under the Medical Care Act, medical advertising guidelines, and the Act against Unjustifiable Premiums and Misleading Representations, claims of guaranteed efficacy or safety, comparative superiority, before/after imagery, testimonials, and omitted risk disclosure are reviewed individually.
Diagnose where Japanese patient acquisition stalls
Trace the patient journey from registration to booking to see exactly where it drops off, then decide together whether a diagnostic engagement is the right next step.